A Growing Global Crisis: Alzheimer’s disease is affecting millions of aging adults, and early intervention is frequently hindered by diagnoses that occur far too late in the disease’s progression.
The Viral Trigger: Emerging clinical research suggests that the varicella zoster virus (the pathogen responsible for both chickenpox and shingles) can activate other dormant viruses within neurons that may contribute to cognitive changes.
The HSV-1 Connection: Researchers found that VZV could reactivate dormant herpes simplex virus type 1 (HSV-1) in a laboratory-grown neural tissue model, which is associated with increased inflammation and Alzheimer’s-associated proteins.
Widespread Hidden Risk: Nearly half of the global population carries a dormant HSV-1 infection, and the vast majority of adults have been exposed to VZV, making investigating whether viruses contribute to neurodegenerative disease a worthwhile endeavor.
Actionable Preventative Steps: Strategic antiviral management and vaccines may protect against conditions that cause cognitive decline.

The Growing Alzheimer’s Epidemic

Alzheimer’s disease is an incredibly prevalent, progressive, and devastating neurological condition that affects an alarmingly increasing number of adults each year. As the global population ages, the burden of cognitive decline is becoming one of the most pressing public health crises of our time. Currently, researchers estimate that as many as 7.2 million Americans are living with Alzheimer’s. Without a monumental shift in how we understand, treat, and prevent the condition, that figure is projected to nearly double over the next three to four decades.

While the overwhelming majority of individuals suffering from Alzheimer’s disease are over the age of 65, the incidence of young-onset dementia is rising. The true tragedy of the Alzheimer’s epidemic, however, lies in the timeline of disease progression and diagnosis.

The most problematic aspect of Alzheimer’s disease is that the biological damage begins years or even decades before the outward symptoms become visible. By the time noticeable cognitive symptoms, such as short-term memory loss, spatial confusion, behavioral shifts, and linguistic difficulties, prompt patients and their families to seek medical help, the physical deterioration of the brain is typically already well underway.

Because the central nervous system has a limited capacity to repair itself once neurons are destroyed, waiting for symptoms to appear means waiting too long. Discovering the root causes of this hidden, silent deterioration is paramount. Understanding exactly what triggers the condition at a cellular level may very well be the greatest step toward figuring out how to successfully treat, cure, and possibly even prevent the disease entirely.

Side-by-side illustration comparing a healthy brain with intact neural connections and a brain affected by neurodegeneration, highlighting neuronal loss, protein deposits, and structural damage associated with Alzheimer’s disease.

The Surprising Trigger: A Common Viral Infection

For decades, researchers have looked at genetics, lifestyle factors, environmental toxins, and cardiovascular health as the primary drivers of Alzheimer’s disease. However, viral infections are being investigated as potential contributors to the neuroinflammatory processes involved in Alzheimer’s disease.

A collaborative study conducted by researchers at Tufts University and the University of Oxford observed how a common viral infection may trigger severe brain aging and deterioration.

Historically, the brain was thought to be a highly sterile environment, protected from everyday pathogens by the robust blood-brain barrier. However, modern virology has proven that certain viruses have the unique ability to bypass these defenses, enter the nervous system, and take up permanent residence within the body. Understanding how these persistent infections may interact with aging, immune function, and genetic susceptibility to influence long-term brain health could provide important new insights into disease prevention and treatment.

Varicella Zoster Virus: The Catalyst

In their quest to understand the link between viruses and the development of Alzheimer’s disease, the Tufts and Oxford researchers specifically isolated the varicella zoster virus (VZV) as a potential instigator.

VZV is a highly contagious pathogen and is the exact same virus responsible for causing chickenpox. While modern pediatric vaccination efforts have been able to keep the initial spread of the virus under much better control, billions of adults still carry the legacy of their childhood infections.

Once a person recovers from chickenpox, the varicella zoster virus does not leave the body. Instead, it travels along the nerve fibers and retreats into the sensory nerve ganglia—clusters of nerve cells located near the spinal cord. There, the virus enters a state of deep latency. It essentially goes to sleep and may not reappear for decades.

In many adults, as the immune system naturally weakens with advancing age or periods of extreme stress, this latent virus can reactivate. When VZV reactivates in an adult, it travels back down the nerve fibers to the skin, resulting in the agonizingly painful, blistering condition known as shingles.

However, the researchers discovered an even more alarming consequence. The Tufts and Oxford teams found that active VZV infection may trigger inflammatory changes that reactivate other viruses, leading to Alzheimer’s disease.

The Chain Reaction: How the Herpes Virus is Awakened

According to the laboratory-grown brain models created for the study, the presence of VZV alone does not contribute to the “plaques and tangles” that cause Alzheimer’s disease. The danger of the varicella zoster virus is its unique potential to activate another, problematic virus that shares a similar living space: the herpes simplex virus.

Specifically, researchers looked at Herpes Simplex Virus Type 1 (HSV-1). HSV-1 is the viral strain primarily associated with the development of oral cold sores and fever blisters around the mouth and lips. After an initial infection, which often occurs in childhood or early adulthood through simple acts like sharing a drink or a kiss, HSV-1 establishes lifelong latency in nerve cells and can reactivate periodically throughout life.

Researchers have detected HSV-1 genetic material in the brains of many older adults, leading scientists to investigate whether repeated viral reactivation could contribute to neurodegenerative disease. For most individuals, this dormant HSV-1 will rarely, if ever, cause noticeable neurological symptoms on its own.

However, the study showed that when neurons infected with dormant HSV-1 were exposed to VZV, HSV-1 reactivated, leading to increased levels of amyloid-beta and tau proteins, as well as inflammatory changes.

Medical illustration of neuroinflammation showing activated immune cells, inflamed neurons, and brain tissue affected by inflammatory processes associated with neurodegenerative disease.

The Biological Mechanism: Amyloid Beta, Tau, and Neuroinflammation

Alzheimer’s disease is characterized by two distinct abnormalities in the brain: the buildup of amyloid-beta plaques (sticky protein fragments that clump together outside of neurons) and tau protein tangles (twisted fibers that build up inside the cells). These proteins slow cell communication and cause neurons to die.

The collaborative research out of Tufts and Oxford demonstrated how this viral dynamic may contribute to brain degeneration:

Protein Accumulation: Reactivated HSV-1 was associated with increased production of amyloid-beta and tau proteins, two biological hallmarks of Alzheimer’s disease.
Neuroinflammation: VZV is known to cause inflammation in the brain, which can contribute to a cycle: Repeated reactivation of HSV, causing inflammation, and increased plaques and proteins.
Loss of Neuronal Function: This inflammation and plaque accumulation result in neuronal death and cognitive impairment.

The researchers did highlight an important and somewhat reassuring piece of nuance in their findings: exposure to VZV without the underlying presence of HSV-1 in the brain did not cause the accumulation of amyloid plaques and proteins. The mechanism seems to lie in the interplay between two seemingly “harmless” viruses.

Repeated cycles of HSV-1 activation, whether by VZV, other viruses, or other external causes, can lead to increased inflammation in the brain, higher production of toxic plaques, and compounding neurodegeneration.

Global Risk Factors: The Silent Passengers

When we look at this viral trigger through the lens of global epidemiology, the statistical overlap of these two viruses paints a deeply concerning picture for public health.

Massive HSV-1 Prevalence: The herpes simplex virus is incredibly common. The World Health Organization estimates that roughly 3.8 billion people under the age of 50 are currently living with an HSV-1 infection. For the vast majority of these billions of people, the virus is asymptomatic and resting quietly in their nerve cells.
Nearly Universal VZV Exposure: Furthermore, the Centers for Disease Control and Prevention notes that up to 90% of people who are not immune will contract chickenpox, meaning that 9 out of 10 adults carry dormant VZV in their bodies.

Given the statistics mentioned above, it is incredibly difficult to avoid exposure to the HSV-1 and varicella virus over a normal lifespan. Chances are high that you have been infected, and the viruses are merely remaining dormant in your body.

Because both viruses are so widespread, millions of aging adults may be unknowingly carrying the exact combination of latent infections being investigated for their possible role in Alzheimer’s disease. While genetics and other health factors affect brain aging, studies like the Tufts and Oxford study suggest that viruses may also contribute to neurodegenerative changes in susceptible individuals.

Prevention and Management Strategies

While the statistics may seem daunting, there is actually a great deal of good news. Because researchers have identified a potential catalyst (VZV) that triggers HSV-1, there are highly actionable means of treating, managing, and preventing this problem.

If VZV can be suppressed, the dormant virus may never wake up to cause neurological damage, rendering it relatively harmless.

Strategic Antiviral Medications: For individuals who suffer from recognized, active HSV-1 outbreaks (such as frequent cold sores), viral symptoms can be managed using prescription antiviral medications, such as acyclovir. While there is no known cure that completely eradicates the herpes virus from the body, these medications drastically reduce viral replication. Keeping the viral load low can limit the stress and inflammation on the nervous system.
Preventing VZV Reactivation: If you’ve already suffered from chickenpox as a child, your primary goal in adulthood is preventing shingles. The modern shingles vaccine is highly effective at bolstering the immune system‘s ability to keep VZV locked in its dormant state. By preventing VZV reactivation, you remove one of the triggers for reactivating HSV-1.
Prioritizing Overall Immune Health: As we age, our immune system naturally experience a phenomenon called immunosenescence—a gradual weakening of our defense mechanisms. Maintaining robust immune function is critical to keeping latent viruses firmly in their dormant state. High-quality sleep, a nutrient-dense diet rich in antioxidants, regular cardiovascular exercise, and rigorous stress management all play a vital role in preventing the systemic inflammation that contributes to chronic disease.

By taking active, informed precautions to manage these ultra-common viruses, you are not just preventing uncomfortable rashes or cold sores; you may very well be taking steps to preserve your long-term brain health.

While Alzheimer’s disease remains a complex condition influenced by genetics, aging, lifestyle, and environmental factors, emerging research continues to highlight the importance of addressing underlying biological processes long before symptoms appear. Supporting immune health, reducing chronic inflammation, managing viral reactivation when appropriate, and maintaining healthy cellular function may all contribute to preserving cognitive resilience as we age. As scientists continue to investigate these connections, one message is becoming increasingly clear: prevention is most effective when it begins years before cognitive decline becomes noticeable.

Because healthy aging depends not only on protecting the brain but also on supporting the body’s ability to repair and renew itself at the cellular level, many people choose to complement a healthy lifestyle with targeted nutritional support. Promoting healthy cellular maintenance, metabolic balance, and the body’s natural repair mechanisms may help support long-term vitality and provide another proactive strategy for maintaining health and resilience throughout the aging process.

Did you know that there is an enzyme in the body, called mTOR, that dictates how fast we age and repair our cells? Even more fascinating, this enzyme goes hand in hand with chronic and metabolic diseases, which is why it is vital to control it. Our Restore Life formula contains 7 proven natural mTOR-inhibiting ingredients, specifically designed to “switch off the aging button.”

Click here to learn more about Restore Life and see how to boost your metabolism even more, protect your skin against aging, and “turn back the clock” by 10 years.

Frequently Asked Questions (FAQ)

Can getting cold sores mean I will definitely get Alzheimer’s disease? Absolutely not. Having an HSV-1 infection (the virus that causes cold sores) does not guarantee that you will develop Alzheimer’s disease. Nearly half the global population carries this virus, and only a fraction will develop dementia. The risk appears to increase when the dormant virus in the brain is repeatedly reactivated by severe neuroinflammation or secondary infections, like the varicella zoster virus. If the virus remains dormant, the risk remains low. Genetics, age, cardiovascular health, and other factors remain major contributors to Alzheimer’s disease risk.
If I had chickenpox as a child, am I automatically at risk for brain aging? If you had chickenpox, it simply means the varicella zoster virus is currently dormant in your nerve tissue. As you age, and if your immune system naturally weakens, this virus can reactivate in the form of shingles. Having had chickenpox creates the potential for risk, which is why managing your immune health as you age is so vital.
Does the shingles vaccine protect against Alzheimer’s disease? The shingles vaccine is explicitly designed and approved to prevent shingles (which is the reactivated form of the varicella zoster virus). However, based on the latest emerging medical theories and virology research, preventing VZV reactivation has been shown to reduce the risk of dementia. By stopping the chain reaction before it starts, there is the potential to reduce your risk of Alzheimer’s disease, though at present, the shingles vaccine is only approved to prevent shingles.
Are there cures for these underlying viral infections? Currently, there is no medical cure that completely eradicates either the herpes simplex virus (HSV-1) or the varicella zoster virus (VZV) from the human body once an infection has occurred. However, highly effective antiviral treatments and vaccines exist that can suppress viral replication, manage symptoms, and keep viruses in a harmless, dormant state.

Sources List

Potential Involvement of Varicella Zoster Virus in Alzheimer’s Disease via Reactivation of Quiescent Herpes Simplex Virus Type 1

TuftsNOW: Common Viruses May Be Triggering the Onset of Alzheimer’s Disease

2025 Alzheimer’s disease facts and figures

Global burden of young-onset dementia, from 1990 to 2021: an age-period-cohort analysis from the global burden of disease study 2021

Herpes Simplex Virus Fact Sheet

Chickenpox (Varicella) – About the Disease

We created ZONIA because we believe that everyone deserves to be empowered with the education and tools to be healthy and happy. Zonia's original videos and personalized transformation programs by our health & wellness experts will help you achieve this mission. Click on the button below to get started today:

join zonia now

We are about to change your life forever! By joining ZONIA you will get an instant access to 500+ original short-form videos across 25+ original shows that present groundbreaking information and practical daily actions that will empower you to transform your life. Join thousands others and become Zonia member today!

more info

About Us Our Team ZoniaOur Experts Editorial Process Contact us FAQ Do not sell or share my personal information